Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The method for treating the cognitive disorders in the patients with dyscirculatory encephalopathy stage II provides for the conventional therapy comprising neuroprotectors, antiaggregants, peripheral vasodilatators and infusion therapy. In addition, Mema composition is used at a dose of 10 mg once a day for 2 months.
UAU201400467U2014-01-202014-01-20Method for treating cognitive disorders in patients with dyscirculatory encephalopathy stage ii
UA91183U
(en)